New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A2081

Introduced
1/9/24  

Caption

Prohibits sale of certain cleaning products containing triclosan.

Impact

The implementation of this bill could significantly impact state laws regarding consumer health and safety in New Jersey. In line with similar regulations in states like Minnesota, A2081 seeks to enhance consumer protection by banning a chemical that has raised health concerns amongst public health officials and consumers alike. It is estimated to affect manufacturers of cleaning products, who may need to reformulate their products or face civil penalties for violations. The new law would take effect one year after its enactment, allowing businesses time to transition away from triclosan-based products.

Summary

Assembly Bill A2081 aims to prohibit the sale of certain cleaning products containing triclosan, a chemical often used in sanitizing and personal cleansing products. The bill specifies that all cleaning products intended for sanitizing or hand and body cleansing must not contain triclosan unless they have received explicit approval from the United States Food and Drug Administration (FDA) for consumer use. The measure highlights growing concerns about the safety and effectiveness of triclosan, especially following FDA findings that indicated it may not be more effective than plain soap and water and is linked to possible negative health effects, including hormone disruption and antibiotic resistance.

Contention

While the bill has garnered support due to the potential health benefits of removing triclosan from common consumer products, there may be contention surrounding the economic implications for manufacturers who rely on this ingredient. Some opponents argue that the bill could disproportionately affect small businesses that may struggle with the costs of reformulation. Furthermore, discussions may arise regarding the adequacy of FDA approval processes for other sanitizer alternatives, as the bill allows exceptions for products with specific FDA clearance, potentially leading to debates over what constitutes safe and effective cleaning agents.

Companion Bills

NJ A1428

Carry Over Prohibits sale of certain cleaning products containing triclosan.

Previously Filed As

NJ A1854

Prohibits sale of certain cleaning products containing triclosan.

NJ S05363

Prohibits the sale of cleaning products containing triclosan, triclocarban or derivatives of such antibacterial compounds.

NJ A1859

Prohibits use of receipt paper containing bisphenol A.

NJ A1740

Prohibits sale of cosmetic products and personal care products containing 1,4-dioxane.

NJ A2063

Prohibits sale and distribution of nail products containing dibutyl phthalates, toluene, or formaldehyde.

NJ A425

Increases penalties for certain prohibited sales of tobacco and vapor products.

NJ A1851

Prohibits use of paper receipts containing bisphenol-A or bisphenol-S; provides for phased-in prohibition on use of all paper receipts; authorizes continued use of electronic receipts.

NJ S2075

Prohibits the sale of certain children's products containing lead, mercury, or cadmium.

NJ A2317

Prohibits forcibly feeding certain poultry for production of foie gras.

NJ A4705

Prohibits sale of crayon and chalk products containing lead.

Similar Bills

NJ A1854

Prohibits sale of certain cleaning products containing triclosan.

FL S0196

Chemicals in Consumer Products

VA HB998

Menstrual products ingredient labeling; restriction of substances, delayed effective date.

VA HB998

An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1, relating to menstrual products ingredient labeling; civil penalty.

MI HB5892

Trade: consumer goods and services; use of certain chemicals in cosmetic products; prohibit. Creates new act.

ME LD317

An Act to Enact the Safe Cosmetics Act

NY A09503

Restricts certain substances from being used in menstrual products; relates to the effectiveness of such provisions.

NY S08816

Restricts certain substances from being used in menstrual products; relates to the effectiveness of such provisions.